Juan Fortea

24.0k total citations · 3 hit papers
205 papers, 5.0k citations indexed

About

Juan Fortea is a scholar working on Physiology, Psychiatry and Mental health and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Juan Fortea has authored 205 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Physiology, 91 papers in Psychiatry and Mental health and 53 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Juan Fortea's work include Alzheimer's disease research and treatments (87 papers), Dementia and Cognitive Impairment Research (85 papers) and Down syndrome and intellectual disability research (50 papers). Juan Fortea is often cited by papers focused on Alzheimer's disease research and treatments (87 papers), Dementia and Cognitive Impairment Research (85 papers) and Down syndrome and intellectual disability research (50 papers). Juan Fortea collaborates with scholars based in Spain, United States and United Kingdom. Juan Fortea's co-authors include Alberto Lleó, Daniel Alcolea, María Carmona‐Iragui, Rafael Blesa, José Luís Molinuevo, Jordi Clarimón, Raquel Sánchez‐Valle, Albert Lladó, Jordi Pegueroles and Eduard Vilaplana and has published in prestigious journals such as The Lancet, JAMA and Nature Medicine.

In The Last Decade

Juan Fortea

188 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Alzheimer's disease associated with Down syndrome: a genetic form of dementia

2021 170 citations Juan Fortea, Shahid Zaman et al. profile →
APOE4 homozygosity represents a distinct genetic form of Alzheimer’s disease

2024 140 citations Juan Fortea, Jordi Pegueroles et al. Nature Medicine profile →
Diagnostic performance of plasma pTau217, pTau181, Aβ1-42 and Aβ1-40 in the LUMIPULSE automated platform for the detection of Alzheimer disease

2024 48 citations Javier Arranz, Nuole Zhu et al. Alzheimer s Research & Therapy profile →

Peers

Countries citing papers authored by Juan Fortea

Since Specialization

Citations

This map shows the geographic impact of Juan Fortea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Fortea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Fortea more than expected).

Fields of papers citing papers by Juan Fortea

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan Fortea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Fortea. The network helps show where Juan Fortea may publish in the future.

Co-authorship network of co-authors of Juan Fortea

This figure shows the co-authorship network connecting the top 25 collaborators of Juan Fortea. A scholar is included among the top collaborators of Juan Fortea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan Fortea. Juan Fortea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cerebrospinal fluid lipoprotein-mediated cholesterol delivery to neurons is impaired in Alzheimer's disease and involves APOE4 2025 ·Journal of Lipid Research ·(unknown), Marina Canyelles, David Santos, Noemí Rotllán, Estefanía Núñez, Jesús Vázquez, Daniel Maspoch, Mary Cano‐Sarabia, Qi Zhao, María Carmona‐Iragui, Sònia Sirisi, Alberto Lleó, Juan Fortea, Daniel Alcolea, Francisco Blanco‐Vaca, Joan Carles Escolà‐Gil, Mireia Tondo	0
2	A Novel CHMP2B Splicing Variant in Atypical Presentation of Familial Frontotemporal Lobar Degeneration 2025 ·Annals of Clinical and Translational Neurology ·Sara Rubio‐Guerra, Sara Bernal, (unknown), (unknown), Valle Camacho, Isabel Sala, (unknown), (unknown), (unknown), Miguel Santos‐Santos, Álvaro Carbayo, Janina Turón‐Sans, Ricard Rojas‐García, Daniel Alcolea, Juan Fortea, Alberto Lleó, Oriol Dols‐Icardo, Ignacio Illán‐Gala	1
3	Cerebrovascular co-pathology and cholinergic white matter pathways along the Lewy body continuum 2025 ·Brain Communications ·(unknown), Antonios Tzortzakakis, (unknown), (unknown), Javier Arranz, Víctor Montal, Alexandre Bejanin, Dag Aarsland, Eric Westman, Juan Fortea, Alberto Lleó, Daniel Alcolea, Milica G. Kramberger, Daniel Ferreira	1
4	Serum level changes of the synaptic marker beta-synuclein in Alzheimer’s disease continuum and other dementias 2025 ·Journal of Neurology Neurosurgery & Psychiatry ·Lorenzo Barba, Giovanni Bellomo, Daniel Alcolea, (unknown), Lorenzo Gaetani, Juan Fortea, Samir Abu‐Rumeileh, Alberto Lleó, Lucilla Parnetti, Olivia Belbin, Markus Otto, Patrick Oeckl	0
5	Diagnostic performance of plasma pTau217, pTau181, Aβ1-42 and Aβ1-40 in the LUMIPULSE automated platform for the detection of Alzheimer disease breakdown → 2024 ·Alzheimer s Research & Therapy ·Javier Arranz, Nuole Zhu, Sara Rubio‐Guerra, (unknown), (unknown), María Carmona‐Iragui, Isabel Barroeta, (unknown), Miguel Santos‐Santos, Juan Fortea, Alberto Lleó, Mireia Tondo, (unknown)	48
6	Longitudinal plasma and CSF analyses in Down syndrome. Results from the DABNI cohort 2024 ·Alzheimer s & Dementia ·Daniel Alcolea, Laia Montoliu‐Gaya, María Carmona‐Iragui, Isabel Barroeta, Laura Videla, Bessy Benejam, Javier Arranz, Alberto Lleó, Kaj Blennow, Nicholas J. Ashton, Henrik Zetterberg, Juan Fortea	0
7	What Can We Learn About Alzheimer’s Disease from People with Down Syndrome? 2024 ·Current topics in behavioral neurosciences ·(unknown), (unknown), María Carmona‐Iragui, Juan Fortea	2
8	APOE4 homozygosity represents a distinct genetic form of Alzheimer’s disease breakdown → 2024 ·Nature Medicine ·Juan Fortea, Jordi Pegueroles, Daniel Alcolea, Olivia Belbin, Oriol Dols‐Icardo, Lídia Vaqué‐Alcázar, Laura Videla, Juan Domingo Gispert, Marc Suárez‐Calvet, Sterling C. Johnson, Reisa A. Sperling, Alexandre Bejanin, Alberto Lleó, Víctor Montal	140
9	Cortical Macro‐ and Microstructural Changes in Parkinson's Disease with Probable Rapid Eye Movement Sleep Behavior Disorder 2024 ·Movement Disorders ·(unknown), Víctor Montal, Anna Campabadal, (unknown), Carme Uribe, (unknown), Núria Bargalló, M. J. Martí, Yaroslau Compta, Álex Iranzo, Juan Fortea, Carme Junqué, Bàrbara Segura	5
10	1. Validity and reliability of CAMCOG‐DS2 and other cognitive outcomes measures for clinical trials of AD in DS 2023 ·Alzheimer s & Dementia ·(unknown), André Strydom, (unknown), Juan Fortea, Bessy Benejam, Shahid Zaman, (unknown), Anne‐Sophie Rebillat, Johannes Levin, Sandra Loosli, Mary McCarron, Eimear McGlinchey, Ellen Melbye Langballe, (unknown), Sarah E. Pape, Antonia Coppus, (unknown), (unknown)	0
11	Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer’s disease continuum 2023 ·Alzheimer s Research & Therapy ·Julie Goossens, (unknown), (unknown), (unknown), Juan Fortea, Daniel Alcolea, Alberto Lleó, Olivia Belbin, Eugeen Vanmechelen	11
12	Brain glucose metabolism and gray matter volume in retired professional soccer players: a cross-sectional [18F]FDG-PET/MRI study 2023 ·Arquivos de Neuro-Psiquiatria ·(unknown), Artur Martins Coutinho, Camila de Godoi Carneiro, (unknown), Adalberto Studart‐Neto, Carla Guariglia, Miriam Harumi Tsunemi, (unknown), (unknown), Renato Anghinah, Ricardo Nitríni, Giovanni Guido Cerri, Juan Fortea, Carlos Alberto Buchpiguel, Cláudia da Costa Leite	1
13	Network Tau spreading is vulnerable to the expression gradients of APOE and glutamatergic-related genes 2022 ·Science Translational Medicine ·Víctor Montal, Ibai Díez, Chan Mi Kim, (unknown), Elisenda Bueichekú, (unknown), Alexandre Bejanin, Jordi Pegueroles, Oriol Dols‐Icardo, Patrizia Vannini, Georges El‐Fakhri, Keith A. Johnson, Reisa A. Sperling, Juan Fortea, Jorge Sepulcre	28
14	AMYQ: An index to standardize quantitative amyloid load across PET tracers 2021 ·Alzheimer s & Dementia ·Jordi Pegueroles, Víctor Montal, Alexandre Bejanin, Eduard Vilaplana, (unknown), Miguel Santos‐Santos, Daniel Alcolea, Ignasi Carrió, Valle Camacho, Rafael Blesa, Alberto Lleó, Juan Fortea, (unknown)	14
15	The Clinical and Neuropathological Features of Sporadic (Late-Onset) and Genetic Forms of Alzheimer’s Disease 2021 ·Journal of Clinical Medicine ·(unknown), (unknown), I. C. H. Clare, Juan Fortea, André Strydom, Anne‐Sophie Rebillat, Antonia Coppus, Johannes Levin, Shahid Zaman	25
16	Motor cortex transcriptome reveals microglial key events in amyotrophic lateral sclerosis 2020 ·Neurology Neuroimmunology & Neuroinflammation ·Oriol Dols‐Icardo, Víctor Montal, Sònia Sirisi, (unknown), Laura Cervera‐Carles, Marta Querol‐Vilaseca, Laia Muñoz, Olivia Belbin, Daniel Alcolea, Laura Molina‐Porcel, Jordi Pegueroles, Janina Turón‐Sans, Rafael Blesa, Alberto Lleó, Juan Fortea, Ricard Rojas‐García, Jordi Clarimón	57
17	Diagnosis of prodromal and Alzheimer's disease dementia in adults with Down syndrome using neuropsychological tests 2020 ·Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring ·Bessy Benejam, Laura Videla, Eduard Vilaplana, Isabel Barroeta, María Carmona‐Iragui, Miren Altuna, Sílvia Valldeneu, Susana Fernández, Sandra Giménez, (unknown), (unknown), Alexandre Bejanin, David Bartrés‐Faz, Sebastián Videla, Daniel Alcolea, Rafael Blesa, Alberto Lleó, Juan Fortea	31
18	Cerebrospinal fluid A beta 1–40 peptides increase in Alzheimer’s disease and are highly correlated with phospho-tau in control individuals 2020 ·Alzheimer s Research & Therapy ·Sylvain Lehmann, Julien Dumurgier, Xavier Ayrignac, Cécilia Marelli, Daniel Alcolea, Juan Fortea, Éric Thouvenot, Constance Delaby, Christophe Hirtz, Jérôme Vialaret, (unknown), Élodie Bouaziz-Amar, Jean Laplanche, Pierre Labauge, Claire Paquet, Alberto Lleó, Audrey Gabelle, (unknown)	40
19	Down syndrome, Alzheimer disease, and cerebral amyloid angiopathy: The complex triangle of brain amyloidosis 2019 ·Developmental Neurobiology ·María Carmona‐Iragui, Laura Videla, Alberto Lleó, Juan Fortea	38
20	CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration 2017 ·Neurology ·Daniel Alcolea, Eduard Vilaplana, Marc Suárez‐Calvet, Ignacio Illán‐Gala, Rafael Blesa, Jordi Clarimón, Albert Lladó, Raquel Sánchez‐Valle, José Luís Molinuevo, Guillermo García‐Ribas, Yaroslau Compta, Marı́a José Martı́, Gerard Piñol‐Ripoll, (unknown), Aina Noguera, Ana García‐Martin, Juan Fortea, Alberto Lleó	92

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact